Entrada Therapeutics, Inc. (TRDA) Tops Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of$ 0.65 per share. This compares to loss of $0.78 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 138.46%. A quarter ago, it was expected that this company would post a loss of$ 0.38 per share when it actually produced earnings of $0.68, delivering a surprise of 278.95%. Over the last four quarters, the ...